REMS Communications Could Get Refreshed After Advisory Panel Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Risk Communications Advisory Committee will address methods for presenting REMS information and assessing whether it is reaching the target population.